GPX4 and pancreatic neoplasm: CONCLUSIONS: Dronedarone serves as an unrecognized promoter of ferroptosis in pancreatic cancer by targeting p62-mediated autophagic degradation and functional inactivation of GPX4, providing a mechanistic and translational rationale for exploiting ferroptosis in pancreatic cancer.